Physician profile
Tabitha E Cox
NPI 1013240688
$1,098.35
in general payments reported to CMS, 2019-2025
11 companies · $211 in 2025
The $211 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $261 · 2022: $233 · 2023: $176 · 2024: $218 · 2025: $211.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $604.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $604.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $213.86 | 2021-2025 | |
| Exeltis, USA INC. | $180.70 | 2021-2025 | Slynd, Tyblume |
| Organon LLC | $179.24 | 2021-2024 | Nexplanon, Nuvaring |
| Sage Therapeutics, LLC | $111.95 | 2024-2025 | Zurzuvae |
| Agile Therapeutics, INC. | $107.98 | 2021-2022 | |
| Axonics, INC. | $102.37 | 2023-2024 | Axonics |
| Astellas Pharma US INC | $79.54 | 2024-2025 | Veozah |
| Hologic Sales and Service, LLC | $49.35 | 2022-2024 | Aptima, Thinprep 2000 Processor |
| Bayer Healthcare Pharmaceuticals INC. | $43.29 | 2021-2025 | |
| Myovant Sciences INC. | $15.68 | 2021 | |
| Therapeuticsmd, INC. | $14.39 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tabitha Cox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.